The Chaudry Laboratory is focused on the function of cyclin A2, a cell cycle regulator, in cardiac development and disease. Read More
Long-Lasting Gene Therapy Benefits Advanced Heart Failure Patients
November 19, 2013 - Cardiovascular Research Center at Mount Sinai report promising long-term follow-up results for its single dose AAV1/SERCA2a gene therapy in advanced heart failure patients.
A Best Manuscript Award Goes to the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai
November 17, 2013 - Editors of Circulation Research recognize Mount Sinai Heart researchers at AHA Scientific Sessions 2013 for their work to repair and reverse heart attack damage.